A Childhood Inflammatory Myopathy with Cytochrome Oxidase Deficiency: Which Came First, the Chicken or the Egg?

Inflammatory myopathies are autoimmune disorders rarely seen in childhood. Normally high-dose corticosteroid is the current treatment for inflammatory myopathies. For a specific subgroup of patients with inflammatory myopathy with cytochrome oxidase (COX)-negative myofibers that do not typically res...

Full description

Saved in:
Bibliographic Details
Main Authors: Gülden Diniz (Author), Önder Yavaşcan (Author), Ümit Başak Şarkış (Author), Zübeyde Yıldırım (Author), Caner Alparslan (Author), Can Öztürk (Author), Afig Berdeli (Author)
Format: Book
Published: Galenos Publishing House, 2023-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_cd356d91f39e42a7ba960b068e3f6765
042 |a dc 
100 1 0 |a Gülden Diniz  |e author 
700 1 0 |a Önder Yavaşcan  |e author 
700 1 0 |a Ümit Başak Şarkış  |e author 
700 1 0 |a Zübeyde Yıldırım  |e author 
700 1 0 |a Caner Alparslan  |e author 
700 1 0 |a Can Öztürk  |e author 
700 1 0 |a Afig Berdeli  |e author 
245 0 0 |a A Childhood Inflammatory Myopathy with Cytochrome Oxidase Deficiency: Which Came First, the Chicken or the Egg? 
260 |b Galenos Publishing House,   |c 2023-12-01T00:00:00Z. 
500 |a 2822-4469 
500 |a 10.4274/jbuch.galenos.2023.45556 
520 |a Inflammatory myopathies are autoimmune disorders rarely seen in childhood. Normally high-dose corticosteroid is the current treatment for inflammatory myopathies. For a specific subgroup of patients with inflammatory myopathy with cytochrome oxidase (COX)-negative myofibers that do not typically respond to corticosteroid treatment, and methotrexate (MTX) is used for therapy. Herein we present a 10-year-old girl who initially received clinical diagnosis of juvenile inflammatory myopathy which did not respond to corticosteroid treatment. Examination of her muscle biopsy specimen showed the presence of COX-negative muscle fibers which are very rarely seen in childhood inflammatory myopathies, and she was diagnosed as inflammatory myopathy characterized with COX-negative myofibers. The patient, who recovered with MTX therapy underwent genetic examination 3 years after the treatment was terminated. The sequence analyses of mitochondrial DNA (mtDNA) identified 19 variants in the rRNA, ND2, ND4, ND5, COX1, COX3, and CytB genes of the mtDNA of the patient and her mother. These mutations generally induce the production of synonym amino acids. However, four missense mutations on the ND4, ATP6, and CytB genes have caused structural changes in amino acids. None of these mutations have been previously reported as pathogenic variants. We have thought that these variations in such essential genes might destabilize mtDNA and could probably affect the ATP synthesis in our patient. Our final diagnosis was established based on abnormal inflammatory response induced by a hereditary mtDNA defect in a child with mitochondrial myopathy, rather than an inflammatory myopathy with COX deficiency. 
546 |a EN 
690 |a childhood inflammatory myopathy 
690 |a polymyositis with cox-negative myofibers 
690 |a atp6 synthase gene 
690 |a nd4 gene 
690 |a cytb gene 
690 |a mitochondrial myopathy 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Journal of Behçet Uz Children's Hospital, Vol 13, Iss 3, Pp 198-202 (2023) 
787 0 |n https://jag.journalagent.com/z4/download_fulltext.asp?pdir=behcetuz&un=BUCHD-45556 
787 0 |n https://doaj.org/toc/2822-4469 
856 4 1 |u https://doaj.org/article/cd356d91f39e42a7ba960b068e3f6765  |z Connect to this object online.